TR201200211A2 - Risedronat içeren farmasötik granüller. - Google Patents
Risedronat içeren farmasötik granüller.Info
- Publication number
- TR201200211A2 TR201200211A2 TR2012/00211A TR201200211A TR201200211A2 TR 201200211 A2 TR201200211 A2 TR 201200211A2 TR 2012/00211 A TR2012/00211 A TR 2012/00211A TR 201200211 A TR201200211 A TR 201200211A TR 201200211 A2 TR201200211 A2 TR 201200211A2
- Authority
- TR
- Turkey
- Prior art keywords
- granules containing
- containing risedronate
- pharmaceutical granules
- risedronate
- pharmaceutical
- Prior art date
Links
- IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 title abstract 2
- 229940089617 risedronate Drugs 0.000 title abstract 2
- 239000008187 granular material Substances 0.000 title 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Packages (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
Mevcut buluş kemik erimesi ve ilişkili hastalıkların önlenmesinde ve tedavisinde kullanılmak üzere risedronat içeren farmasötik formülasyonlara ilişkindir.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2012/00211A TR201200211A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren farmasötik granüller. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2011/00149A TR201100149A2 (tr) | 2011-01-06 | 2011-01-06 | Geliştirilmiş risedronat formülasyonu. |
| TR2012/00211A TR201200211A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren farmasötik granüller. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201200211A2 true TR201200211A2 (tr) | 2012-07-23 |
Family
ID=45787321
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2011/00149A TR201100149A2 (tr) | 2011-01-06 | 2011-01-06 | Geliştirilmiş risedronat formülasyonu. |
| TR2012/00212A TR201200212A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren geliştirilmiş formülasyonlar. |
| TR2012/00211A TR201200211A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren farmasötik granüller. |
| TR2012/00213A TR201200213A2 (tr) | 2011-01-06 | 2012-01-06 | Kombine dozaj formları. |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2011/00149A TR201100149A2 (tr) | 2011-01-06 | 2011-01-06 | Geliştirilmiş risedronat formülasyonu. |
| TR2012/00212A TR201200212A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren geliştirilmiş formülasyonlar. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2012/00213A TR201200213A2 (tr) | 2011-01-06 | 2012-01-06 | Kombine dozaj formları. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2661258B1 (tr) |
| TR (4) | TR201100149A2 (tr) |
| WO (1) | WO2012093980A1 (tr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL77243A (en) | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
| TR200900878A2 (tr) * | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar |
-
2011
- 2011-01-06 TR TR2011/00149A patent/TR201100149A2/tr unknown
-
2012
- 2012-01-06 TR TR2012/00212A patent/TR201200212A2/tr unknown
- 2012-01-06 EP EP12706950.8A patent/EP2661258B1/en active Active
- 2012-01-06 WO PCT/TR2012/000011 patent/WO2012093980A1/en not_active Ceased
- 2012-01-06 TR TR2012/00211A patent/TR201200211A2/tr unknown
- 2012-01-06 TR TR2012/00213A patent/TR201200213A2/tr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2661258B1 (en) | 2016-04-27 |
| EP2661258A1 (en) | 2013-11-13 |
| TR201200212A2 (tr) | 2012-07-23 |
| TR201100149A2 (tr) | 2012-07-23 |
| TR201200213A2 (tr) | 2012-07-23 |
| WO2012093980A1 (en) | 2012-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017501306A1 (en) | Inhibitors of histone demethylases | |
| EA201590165A1 (ru) | Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения | |
| IN2014MN00948A (tr) | ||
| EP3466408C0 (en) | LIQUID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A DISEASE OF THE POSTERIOR EYE | |
| TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
| TW201129382A (en) | Antibody formulation and therapeutic regimens | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| BR112015010663A2 (pt) | formas de dosagem de ruxolitinib de liberação sustentada | |
| IN2014MN02069A (tr) | ||
| EA033374B1 (ru) | Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения | |
| IN2014MN00987A (tr) | ||
| IN2014DN06501A (tr) | ||
| IN2014MN00986A (tr) | ||
| MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
| HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| EP2415763A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF GLAUCOMA | |
| UA116999C2 (uk) | Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить | |
| EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
| EP2849738C0 (en) | HIGH PENETRATION PRODRUG COMPOSITIONS AND ASSOCIATED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY CONDITIONS | |
| EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
| EA201201296A1 (ru) | Способы лечения диабетических язв стопы | |
| NZ702253A (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
| TR201004464A2 (tr) | Kemik erimesi için formülasyon. | |
| CY1116158T1 (el) | Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
| IN2014DN03010A (tr) |